Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02596087 · ClinicalTrials.gov registry record · NA
Improving Quality by Maintaining Accurate Problems in the EHR
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 2,386
- Enrollment target
NCT02596087: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT02596087 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 2,386 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02596087, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,386 participants
- Enrollment target
Study Summary
The overall goal of the IQ-MAPLE project is to improve the quality of care provided to patients with several heart, lung and blood conditions by facilitating more accurate and complete problem list documentation. In the first aim, the investigators will design and validate a series of problem inference algorithms, using rule-based techniques on structured data in the electronic health record (EHR) and natural language processing on unstructured data. Both of these techniques will yield candidate problems that the patient is likely to have, and the results will be integrated. In Aim 2, the investigators will design clinical decision support interventions in the EHRs of the four study sites to alert physicians when a candidate problem is detected that is missing from the patient's problem list - the clinician will then be able to accept the alert and add the problem, override the alert, or ignore it entirely. In Aim 3, the investigators will conduct a randomized trial and evaluate the effect of the problem list alert on three endpoints: alert acceptance, problem list addition rate and clinical quality.
Primary Outcome
Acceptance of the alerts: This first endpoint is descriptive: the acceptance rate for the alerts presented to providers. This will be calculated by taking the total number of acceptances for each alert and dividing it by the total number or unique presentations of the alert. We will conduct a stratified analysis to look at differences in acceptance rates by institution, specialty, disease and provider demographic characteristics, and will report the results in tabular form.
Interventions
- OTHER Problem List Suggestion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,386 participants |
| Start Date | 2016-04 |
| Phase | NA |
What the finished NCT02596087 record still lists
NCT02596087 is an interventional study that assigns participants to a tested intervention. Its 2,386 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% higher).
The record links to 0 conditions, and to 1 intervention - of which Problem List Suggestion is the first listed.
NCT02596087 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02596087 about?
NCT02596087 is a clinical study titled "Improving Quality by Maintaining Accurate Problems in the EHR". The overall goal of the IQ-MAPLE project is to improve the quality of care provided to patients with several heart, lung and blood conditions by facilitating more accurate and complete problem list documentation. In the first aim, the investigators will design and validate a series of problem infere...
What is the current status of trial NCT02596087?
This trial is currently completed. It is a NA study. The enrollment target is 2,386 participants. The study started on 2016-04.
What interventions are being tested in trial NCT02596087?
The interventions under investigation include: Problem List Suggestion (OTHER).
Who is sponsoring clinical trial NCT02596087?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02596087's enrollment target sits among peer trials
2,386 46th of 2000 higher than 1,955 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06747494 · 2,396 participants · NA
General vs Spinal in Total Joint Arthroplasty (TJA)
- NCT05868421 · 2,376 participants · NA
Veteran Social Support for Enhancing Use of Smoking Cessation Treatment
- NCT05185440 · 2,400 participants · NA
Reducing Alcohol Involved Sexual Violence in Higher Education
- NCT05285527 · 2,400 participants · NA
MiSight 1 Day Safety Post-Approval Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia